Login
Walgreens Boots Alliance NASDAQ: WBA
Walgreens Boots Alliance, Inc. operates as a pharmacy-led health and wellbeing company
| Name | Walgreens Boots Alliance |
| Ticker | WBA |
| Exchange | NASDAQ |
| Sector | Health Care |
| Industry | Healthcare Supply Chain & InfoTech |
| Price | 37.21 |
| 52W Low/High | 34.67 / 62.72 |
| Market cap | 32 B |
| 1Y Total Return |
-28.23%
Below Average |
| 1Y Volatility |
44.39%
Less Risk |
Relative Strength Index : Attempt to identify overbought (above 80) and oversold (below 20) conditions
Walgreens Boots Alliance, Inc. operates as a pharmacy-led health and wellbeing company
Details
| Ticker | WBA |
| Name | Walgreens Boots Alliance |
| ISIN | |
| CUSIP | 931427108 |
| Exchange | NASDAQ |
| Sector | Health Care |
| Industry | Healthcare Supply Chain & InfoTech |
| Country | USA |
| Currency | U.S. Dollar |
| In Index(ices) |
|
Share as of 9/17/20
| Close Price | 37.21 |
| 52W Low/High | 34.67 / 62.72 |
| Market cap | 32 B |
| 1Y Total Return |
-28.23%
Below Average |
| 1Y Volatility |
44.39%
Less Risk |
| Beta | 0.91 |
| PE (trailing) |
44.83
High |
| 12M Dividends | 1.83 |
| Last Dividend Date | 8/18/20 |
| Dividend Yield | 4.92% |
Fin. Strength
| Net Profit Margin | 0.5% |
| Cash from Op. / Cur. Liabilities | 0.22 |
| Diluted Earnings / Share | 0.83 |
| ROE | 3.4% |
| ROIC | 3.0% |
| Price / Revenue | 0.2 |
| Price / Book | 1.6 |
| Price / CF | 5.6 |
| Current Ratio | 0.7 |
| Cur.Liabilities / Tot.Liabilities | 0.4 |
| Financial Leverage | 1.96 |
| in Mils USD |
rolling-year up to June
|
||||||
|---|---|---|---|---|---|---|---|
| Income Statement | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
| Revenue |
138,744
|
136,354
|
128,244
|
116,701
|
117,237
|
93,979
|
|
| Gross Profit |
28,440
|
30,424
|
30,557
|
28,753
|
30,208
|
24,986
|
|
| R&D |
0
|
0
|
0
|
0
|
0
|
0
|
|
| EBITDA |
3,569
|
8,207
|
7,639
|
7,509
|
6,324
|
7,344
|
|
| Operating Income |
1,402
|
5,608
|
6,129
|
5,568
|
5,697
|
4,738
|
|
| Net Income exc. Extra |
760
|
4,816
|
4,314
|
4,306
|
3,169
|
3,914
|
|
| per Share | |||||||
| Diluted avg Shares |
875
|
911
|
995
|
1,083
|
1,088
|
1,102
|
|
| EPS exc. Extra |
0.83
|
5.09
|
4.28
|
3.96
|
2.83
|
3.71
|
|
| Dividend |
1.83
|
1.76
|
1.60
|
1.50
|
1.44
|
1.35
|
|
| Div. Yield (an.) |
4.69%
|
3.23%
|
2.68%
|
1.91%
|
1.77%
|
1.51%
|
|
| Balance Sheet | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
| Total Assets |
86,444
|
68,586
|
70,152
|
74,173
|
67,333
|
70,644
|
|
| Cash, Eq & Invt ShortTerm |
768
|
839
|
1,818
|
12,253
|
3,291
|
4,449
|
|
| Total Current Assets |
18,326
|
19,021
|
19,988
|
28,152
|
19,713
|
21,029
|
|
| Total Non-Current Assets |
68,118
|
49,565
|
50,164
|
46,021
|
47,620
|
49,615
|
|
| Intangibles |
25,131
|
28,042
|
29,200
|
25,724
|
27,658
|
28,590
|
|
| Total Liabilities |
65,121
|
43,815
|
41,682
|
42,689
|
36,019
|
38,715
|
|
| Total Current Liabilities |
26,649
|
25,060
|
21,482
|
21,713
|
15,811
|
16,157
|
|
| Long Term Debt |
38,472
|
18,755
|
20,200
|
20,976
|
20,208
|
22,558
|
|
| Shareholder equity |
20,736
|
24,133
|
27,736
|
30,600
|
30,881
|
31,563
|
|
| Cash Flow | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
| Cash from Operations |
5,777
|
6,095
|
7,399
|
7,895
|
6,694
|
5,543
|
|
| Depreciation |
1,973
|
1,982
|
1,710
|
1,691
|
1,749
|
1,579
|
|
| Cash from Investing |
-1,398
|
-1,959
|
-5,502
|
-2,008
|
-2,353
|
-4,070
|
|
| Capex |
1,418
|
1,630
|
1,422
|
1,333
|
1,265
|
1,142
|
|
| Cash from Financing |
-4,472
|
-5,085
|
-12,384
|
3,167
|
-5,431
|
944
|
|
| Stock Issued |
-1,750
|
-6,217
|
-6,127
|
-1,223
|
-1,269
|
-837
|
|
| Debt (LT) Issued |
-1,089
|
2,722
|
-4,268
|
6,155
|
-2,548
|
3,489
|
|
| Free Cash Flow |
4,328
|
10,219
|
13,281
|
2,279
|
5,486
|
3,541
|
|
| Ratios | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
| Net Profit Margin |
0.5%
|
3.5%
|
3.4%
|
3.7%
|
2.7%
|
4.2%
|
|
| NCFO / Op.Income |
412.1%
|
108.7%
|
120.7%
|
141.8%
|
117.5%
|
117.0%
|
|
| Current Ratio |
0.7
|
0.8
|
0.9
|
1.3
|
1.2
|
1.3
|
|
| Financial Leverage D/E |
1.96
|
0.73
|
0.54
|
0.63
|
0.44
|
0.51
|
|
| Return on Capital Avg |
3.0%
|
12.0%
|
11.1%
|
10.3%
|
8.1%
|
10.1%
|
|
| Return on Shareholder Equity |
3.4%
|
18.6%
|
14.8%
|
14.0%
|
10.1%
|
14.8%
|
|
Fundamentals
No documents are available for the moment, please check back soon, or save the asset to be notified when documents are available